Epirubicin

• Mechanism of Action
• Inserted between DNA base pairs, resulting in inhibition of topoisomerase II.

Clinical Use

• • Indication
  • Certain solid organ and haematologic organ malignancies, as guided by cancer specialists and local guidelines.
• • Adverse Effects